Tag: Novartis
Novartis Receives European Commission Approval for Rhapsido®, the First Oral Targeted Therapy for Chronic Spontaneous Urticaria
Novartis has officially received European Commission (EC) approval for Rhapsido® (remibrutinib), marking a historic shift in the management of chronic spontaneous urticaria (CSU). Rhapsido...
NIPER Mohali Partners with Novartis to Advance Industry–Academia Collaboration
By Dose Daily News Bureau
20th April, 2026
19:00 PM IST
The National Institute of Pharmaceutical Education and Research (NIPER) Mohali, has signed a formal collaboration...